Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3144 results

Sort By:

1. SAFE-AI ONCO-TRACK: Multimodal GenAI for Early Detection of Minimal Residual Disease and Recurrence in Gastrointestinal Oncology

Study ID: NCT07189520
Start Date: 2026-06-01
End Date: 2030-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

700

Intervention / Treatment

Artificial Intelligence

Sponsor

Polytechnic University of Marche

Source: clinicaltrials.gov

Share:
Add to list

Immuno-inflammation in the Acute Phase of an Ischaemic Cerebral Accident Managed by Decompressive Hemicraniectomy: a Case-control Study

Study ID: NCT04763161
Start Date: 2026-08-15
End Date: 2027-03-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Decompressive hemicraniectomy

neurosurgical operation

Sponsor

Adolphe de Rothschild Ophthalmological Foundation

Source: clinicaltrials.gov

Share:
Add to list

Cognitive Strategies in Early Psychosis 2

Study ID: NCT07263022
Start Date: 2026-03-15
End Date: 2030-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

24

Intervention / Treatment

Modafinil

D-serine solution

Placebo

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

DDAVP for Pituitary Adenoma

Study ID: NCT04569591
Start Date: 2026-03-11
End Date: 2028-02-26
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

22

Intervention / Treatment

Desmopressin acetate

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Source: clinicaltrials.gov

Share:
Add to list

VLA1553-403 Pregnancy Surveillance Study

Study ID: NCT07414524
Start Date: 2026-03-31
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Live-attenuated CHIKV vaccine VLA1553

Vaccine(s) approved for use during pregnancy by the MoH

Sponsor

Valneva Austria GmbH

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Study ID: NCT07293351
Start Date: 2026-03-26
End Date: 2031-11-26
Study Type

Interventional

Study Phase

Phase2

No. of Participants

234

Intervention / Treatment

Cool down

Ipilimumab

Cabozantinib

Nivolumab

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings

Study ID: NCT07374367
Start Date: 2026-05-01
End Date: 2027-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

66

Intervention / Treatment
Sponsor

Amera Imam Abdel - Ghany Ahmed

Source: clinicaltrials.gov

Share:
Add to list

Methadone Patient Access to Collaborative Treatment

Study ID: NCT06556602
Start Date: 2026-04
End Date: 2030-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1080

Intervention / Treatment

MPACT

Sponsor

University of Arizona

Source: clinicaltrials.gov

Share:
Add to list

LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation

Study ID: NCT07455539
Start Date: 2026-04-01
End Date: 2028-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

LAmbre II Left Atrial Appendage Occluder

Sponsor

Prince of Wales Hospital, Shatin, Hong Kong

Source: clinicaltrials.gov

Share:
Add to list

Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers

Study ID: NCT07217769
Start Date: 2026-06-01
End Date: 2030-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment

No-nap

15-minute nap

30-minute nap

45-minute nap

60-minute nap

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list